- Home
- AVD vs THTX Comparison
AVD vs THTX Comparison
Compare AVD & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- THTX
- Stock Information
- Founded
- AVD 1969
- THTX 1993
- Country
- AVD United States
- THTX Canada
- Employees
- AVD N/A
- THTX N/A
- Industry
- AVD Agricultural Chemicals
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- THTX Health Care
- Exchange
- AVD Nasdaq
- THTX Nasdaq
- Market Cap
- AVD 135.6M
- THTX 119.1M
- IPO Year
- AVD N/A
- THTX N/A
- Fundamental
- Price
- AVD $3.72
- THTX $2.53
- Analyst Decision
- AVD Strong Buy
- THTX Hold
- Analyst Count
- AVD 1
- THTX 1
- Target Price
- AVD $12.00
- THTX N/A
- AVG Volume (30 Days)
- AVD 204.3K
- THTX 138.5K
- Earning Date
- AVD 06-06-2025
- THTX 07-09-2025
- Dividend Yield
- AVD 0.81%
- THTX N/A
- EPS Growth
- AVD N/A
- THTX N/A
- EPS
- AVD N/A
- THTX N/A
- Revenue
- AVD $527,962,999.00
- THTX $88,666,000.00
- Revenue This Year
- AVD N/A
- THTX N/A
- Revenue Next Year
- AVD $3.54
- THTX $15.13
- P/E Ratio
- AVD N/A
- THTX N/A
- Revenue Growth
- AVD N/A
- THTX 13.52
- 52 Week Low
- AVD $3.28
- THTX $1.12
- 52 Week High
- AVD $9.84
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- AVD 35.64
- THTX 49.00
- Support Level
- AVD $4.40
- THTX $2.38
- Resistance Level
- AVD $4.08
- THTX $2.68
- Average True Range (ATR)
- AVD 0.32
- THTX 0.09
- MACD
- AVD -0.11
- THTX -0.02
- Stochastic Oscillator
- AVD 3.09
- THTX 51.72
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.